Information Technology Award announced for pharmacy in 2010

First DataBank Europe (FDBE) is pleased to announce, in association with The Guild of Healthcare Pharmacists (GHP) and the UK Clinical Pharmacy Association (UKCPA), the 2010 FDBE/GHP/UKCPA Information Technology Award.

The annual award, now in its eighth year, is to encourage, support and promote information technology initiatives and best practice in the use of IT in hospital pharmacy. In particular, initiatives are sought where IT has made a positive difference to the provision of pharmaceutical services or resulted in direct benefit to the patients or staff. The award, sponsored by FDBE and aimed at pharmacy departments and individuals, is for the sum of two thousand five hundred pounds.

Projects may be related to patient care, clinical services, medicines management, decision support, electronic prescribing, or any other IT application that improves pharmaceutical services. This year's award has been won by the Pharmacy Department of The Princess of Wales Hospital at Abertawe Bro Morgannwg University NHS Trust. The project team was commended for successfully developing the Electronic Transfer of Care (eTOC), an electronic discharge summary which has replaced the ineffective and error-prone paper process at the hospital.

Last year's winner was the Northumbria Healthcare NHS Trust for its development of a Medicines Management e-learning package to improve the effectiveness of medicines management training across the Trust. In 2007, University College London Hospitals NHS Trust won the award for creating a solution which used IT to manage and electronically store information about clinical trials taking place within the Trust.

Graeme Richardson, Chairman of the IT Interest Group enthuses, "We are delighted that FDBE has chosen to continue to support this award. Year on year the entries we receive are of a very high standard and they demonstrate the positive impact that IT can have upon the way pharmacists work and the way in which services are delivered. We hope that this award will continue to highlight some of the most successful projects and inspire others in the use of information technology."

The deadline for entries is 31 December 2009 and the award will be presented in the spring of 2010. To apply please see the 2010 award leaflet available soon via the awards pages at www.ukcpa.org or www.ghp.org.uk.

About First DataBank Europe
First DataBank Europe (FDBE) is the UK's leading provider of drug knowledge bases and active clinical decision support. With over 25 years' experience of maintaining, developing and integrating drug knowledge bases across the entire healthcare spectrum, FDBE has unrivalled expertise and knowledge in this specialist field. NHS Connecting for Health has chosen FDBE to provide drug-related clinical decision support.

Patient safety is the driving force behind our business. Through the effective integration of our products into clinical systems, we enable safer prescribing, dispensing and administration.

Our Multilex Drug Data File - the UK's most comprehensive and widely used drug knowledge base - is in daily use by thousands of healthcare professionals in the UK.

For further information visit www.firstdatabank.co.uk

GHP/UKCPA
The Guild of Healthcare Pharmacists IT Interest Group formed in 2001 and joined forces with UK Clinical Pharmacy Association in 2006 to establish a joint group. This group now holds an annual seminar. Delegates have an active interest in the implementation of new technologies to support the previsions of pharmacy clinical services.

Most Popular Now

Pfizer and BioNTech receive positive CHMP opinion …

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced a booster dose of their Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine (COMIRNATY® Original/Omicron ...

Vividion Therapeutics names Jenna Goldberg as Chie…

Vividion Therapeutics, Inc., a biopharmaceutical company utilizing novel discovery technologies to unlock high value, traditionally undruggable targets with precision the...

Bayer with continued strong performance

The Bayer Group maintained its strong business performance across all three divisions in the third quarter. "Despite rising inflation and global supply chain problems, we...

Sanofi and GSK's next-generation COVID-19 booster …

After the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for VidPrevtyn® Beta, the vaccine was approved by t...

GSK announces positive Phase IIa study results for…

GSK plc (LSE/NYSE: GSK) announced positive results from a Phase IIa study demonstrating that GSK3036656, a first-in-class investigational antitubercular agent, was well t...

Sugar molecules as a target in cancer therapy

Cancer cells use sugar molecules on their surface to disable attacks by the body's immune system. Researchers at the University of Basel now report on how this mechanism ...

COVID vaccination improves effectiveness of cancer…

Patients with nasopharyngeal cancer are often treated with drugs that activate their immune system against the tumor. Until now, it was feared that vaccination against Co...

Making melanoma immortal: Pitt scientists discover…

Scientists at the University of Pittsburgh School of Medicine have discovered the missing puzzle piece in the mystery of how melanoma tumors control their mortality. I...

Unusual type of antibody shows ultrapotent activit…

An unusual type of antibody that even at miniscule levels neutralizes the Zika virus and renders the virus infection undetectable in preclinical models has been identifie...

New drug shows promise for fighting both COVID-19 …

While vaccination can provide life-saving protection against COVID-19, scientists are still searching for ways to treat severe infections, including in people who cannot ...

Machine learning can help predict patient response…

Predicting which patients will respond well to treatment is a quandary that has plagued the field of cancer immunotherapy for more than four decades. Now, researchers at ...

Study reveals vaccine confidence declined consider…

A new study suggests that, despite the success of the COVID-19 vaccination campaigns, vaccine confidence has declined significantly since the start of the pandemic. Re...